Related Experiment Video
Updated: Aug 28, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana
Sophia Fontana1, Ladan Panahi1, George Udeani1
1Pharmacy Practice, Texas A&M University, Kingsville, USA.
Insights
This case report details a patient with cardiovascular complications from chronic methamphetamine and cannabis use. It highlights cardiotoxicity, including heart failure and hypercoagulable state, from this drug combination.
Area of Science:
- Cardiology
- Toxicology
- Pharmacology
Background:
- Cardiotoxicity from chronic methamphetamine use is documented.
- Cardiovascular effects of cannabis, especially in combination with methamphetamine, are not well-established.
- Increasing interest in medical marijuana necessitates understanding its adverse effects.
Observation:
- A 51-year-old male presented with cardiovascular complications.
- The patient exhibited cardiotoxicity, including congestive heart failure (CHF) exacerbation, a hypercoagulable state, and electrolyte abnormalities.
- These complications arose in the context of chronic methamphetamine and cannabis use.
Findings:
- The case demonstrates significant cardiotoxicity associated with the simultaneous use of methamphetamine and cannabis.
- Observed effects included acute to chronic congestive heart failure (CHF) exacerbation, hypercoagulable state, and electrolyte imbalances.
- This highlights a potential adverse effect profile for combined drug use.
Implications:
- This case underscores the need for further research into the cardiovascular risks of combined methamphetamine and cannabis use.
- Understanding the toxicity profile is crucial given the increasing use of marijuana, even for medical purposes.
- The findings are relevant to clinical practice and public health, especially concerning poly-substance abuse patterns.
Abstract:
We present the case of a 51-year-old male admitted for cardiovascular complications in the face of concomitant chronic methamphetamine and cannabis use. Upon further assessment, the patient exhibited cardiotoxicity, including acute to chronic congestive heart failure (CHF) exacerbation, hypercoagulable state, and electrolyte abnormalities. Cardiotoxicity secondary to chronic methamphetamine use has been established. However, marijuana's cardiovascular effects have not been well established. Even less information exists about the simultaneous use of methamphetamine and cannabis. With increasing interest in the use of marijuana for medical purposes, it is imperative to study any corresponding toxicity and adverse effect profile. The worldwide pattern of drug co-administration also brings the importance of this topic to light. This case report serves to provide insight into this information gap.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

